Your browser doesn't support javascript.
loading
Genome sequencing identifies a rare case of moderate Zellweger spectrum disorder caused by a PEX3 defect: Case report and literature review.
Lee, Whiwon; Costain, Gregory; Blaser, Susan; Walker, Susan; Marshall, Christian R; Gonorazky, Hernan; Inbar-Feigenberg, Michal.
Afiliación
  • Lee W; Centre for Genetic Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Costain G; Centre for Genetic Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Blaser S; Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Walker S; Department of Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Marshall CR; The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Gonorazky H; Centre for Genetic Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Inbar-Feigenberg M; Genome Diagnostics, Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
Mol Genet Metab Rep ; 25: 100664, 2020 Dec.
Article en En | MEDLINE | ID: mdl-33101983
ABSTRACT
Defects in PEX3 are associated with a severe neonatal-lethal form of Zellweger spectrum disorder. We report two moderately affected siblings whose clinical and biochemical phenotypes expand the reported spectrum of PEX3-related disease. Genome sequencing of an adolescent male with progressive movement disorder, spasticity and neurodegeneration, and previous non-diagnostic plasma very-long chain fatty acid analysis, revealed a homozygous likely pathogenic missense variant in PEX3 [c.991G > A; p.(Gly331Arg)]. A younger sibling with significant motor decline since the age of three years was also subsequently found to be homozygous for the familial PEX3 variant. A comprehensive review of the scientific literature identified three additional families with non-lethal infantile- or childhood-onset PEX3-related disease, which together with this clinical report illustrate the potential for highly variable disease severity. Our findings demonstrate the diagnostic utility of genome-wide sequencing for identifying clinically and biochemically heterogeneous inherited metabolic disorders such as the peroxisome biogenesis disorders.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Genet Metab Rep Año: 2020 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Genet Metab Rep Año: 2020 Tipo del documento: Article País de afiliación: Canadá